Trial Profile
An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Biomarker; Therapeutic Use
- 18 Jan 2011 New trial record